Vancomycin
Vancomycin is an antibiotic used to treat serious bacterial infections including blood infections, infective endocarditis, skin and bone infections, lower respiratory tract infections, and — when taken by mouth — C. difficile-associated diarrhea and staphylococcal enterocolitis.
🧬 Where this information comes from Click to expand
The clinical label records used on this page are FDA-filed Structured Product Labeling (SPL) retrieved through openFDA. We identified 57 clinical label sets within the page’s selected clinical scope after exact ingredient or ingredient-combination matching and applicable route/form matching. Forms, routes, brands, labelers, strengths, and NDC product-record counts are built separately from matching FDA National Drug Code Directory records. The linked DailyMed document is a representative official source for verification, not the page’s only clinical source. View the linked label on DailyMed →
⚠️ FDA Boxed Warning — the FDA’s strongest safety alert ▾
One specific injectable formulation of vancomycin — containing the additives PEG 400 and N-acetyl D-alanine (NADA) — should NOT be used during the first or second trimester of pregnancy. In animal studies, these additives (not vancomycin itself) caused fetal bone and heart malformations at high doses. If you need vancomycin during early pregnancy, your doctor should use a different formulation that does not contain these additives. Be sure to tell your doctor if you are pregnant or could become pregnant before receiving any IV vancomycin.
📖 Vancomycin: Patient Information Guide
A plain-language walkthrough of Vancomycin — what it treats, how it works, how it’s taken, side effects, warnings and interactions. Tap any section to expand it.
🎯What it's used for▾
Vancomycin is an antibiotic active against serious gram-positive bacterial infections. Approved uses vary by form and route:
- IV formulations (including Tyzavan, Vancomycin Injection, and Vancomycin Hydrochloride for Injection): treat septicemia (serious bloodstream infection), infective endocarditis (heart valve infection), skin and skin structure infections, bone infections, and lower respiratory tract infections — in adults and children, including newborns in some formulations
- Oral capsules (including Vancocin and Vancomycin Hydrochloride Capsules): treat Clostridioides difficile-associated diarrhea and staphylococcal enterocolitis (including MRSA strains) in adults and pediatric patients under 18
- Oral solution/liquid (including Firvanq and Vancomycin Hydrochloride for Oral Solution): treat C. difficile-associated diarrhea and staphylococcal enterocolitis in adults and pediatric patients under 18
- The IV form does not work for C. diff or gut infections; the oral form does not work for bloodstream, bone, heart, skin, or lung infections
⚙️How it works▾
Vancomycin kills bacteria by blocking cell wall construction. Bacteria need a strong outer wall to survive; vancomycin binds to key building blocks needed to assemble that wall, causing the bacteria to fall apart. It also disrupts the bacterial cell membrane and interferes with RNA synthesis (how bacteria make proteins). Together, these actions kill the bacteria rather than just slowing their growth.
Vancomycin works only against gram-positive bacteria — a specific class that includes MRSA and certain streptococci — and has no activity against gram-negative bacteria, fungi, or mycobacteria. There is no cross-resistance between vancomycin and other antibiotic classes, which is part of why it's used when other antibiotics have failed.
💊How it's taken▾
How and how often vancomycin is given depends on the form and what's being treated — always follow your prescriber's exact instructions.
- IV (intravenous): Given in a healthcare setting, infused slowly into a vein over at least 60 minutes. The frequency depends on kidney function, weight, and the infection being treated. Food timing is not relevant for IV dosing.
- Oral capsules (e.g., Vancocin): Taken by mouth several times a day, typically for 7 to 10 days. Can be taken with or without food. Complete the full course even if you feel better.
- Oral liquid solution (e.g., Firvanq): Also taken by mouth multiple times a day for 7 to 10 days. The solution is prepared by a pharmacist before dispensing.
If you miss a dose, take it as soon as you remember — unless it's almost time for your next dose. Do not double up. Never switch between oral and IV forms on your own.
🤒Side effects — in detail▾
Side effects vary depending on whether you receive vancomycin by IV or by mouth.
- Oral vancomycin (most common, over 10%): nausea, abdominal pain, low potassium (hypokalemia)
- Also reported with oral use: vomiting, diarrhea, gas, fever, swelling, headache, fatigue, urinary tract infection
- IV and oral (both): kidney injury, hearing loss, ringing in the ears (tinnitus), dizziness, low white blood cell count (neutropenia)
- IV-specific: flushing/redness of the face and upper body, low blood pressure, wheezing, chest pain, vein irritation (phlebitis) at the infusion site
- Rare but serious: severe allergic reactions (anaphylaxis), life-threatening skin reactions (Stevens-Johnson syndrome, toxic epidermal necrolysis), cardiac arrest with rapid infusion
Call your doctor or get emergency help right away for signs of kidney problems, hearing changes, severe skin reactions, or any difficulty breathing.
⚠️Warnings & precautions▾
- Kidney damage (nephrotoxicity): The biggest risk with vancomycin. Both IV and oral use can cause acute kidney injury. Risk is higher with prolonged use, high doses, existing kidney disease, older age, dehydration, and when combined with other kidney-stressing drugs. Kidney function and vancomycin levels are monitored throughout treatment.
- Hearing damage (ototoxicity): Can cause ringing in the ears, hearing loss, or dizziness — sometimes permanently. Higher risk in older patients, those with pre-existing hearing loss, and those also taking aminoglycoside antibiotics.
- Severe skin reactions: Rare but potentially life-threatening reactions including toxic epidermal necrolysis (TEN) and Stevens-Johnson syndrome (SJS) have been reported. Stop vancomycin immediately if blistering, peeling skin, or mouth sores appear.
- Infusion reactions (IV only): Rapid infusion can cause a dramatic drop in blood pressure, shock, or cardiac arrest. Always infuse over at least 60 minutes. A "vancomycin infusion reaction" (red man syndrome) — flushing, itching, and redness of the face and upper chest — can occur, especially with fast infusion rates.
- Low white blood cell count (neutropenia): Reported with both IV and oral use; your doctor may monitor your blood counts during prolonged treatment.
- C. diff colitis: Like all antibiotics, vancomycin (when given by IV) can disrupt gut bacteria and trigger C. difficile overgrowth, causing diarrhea or colitis — even weeks after stopping treatment.
🔀What it interacts with▾
Vancomycin has several important drug interactions to be aware of:
- Piperacillin/tazobactam (Zosyn): Combining this antibiotic with vancomycin significantly increases the risk of acute kidney injury. Kidney function should be closely monitored.
- Anesthetic agents: Using vancomycin around the time of general anesthesia has been associated with skin flushing and histamine-like reactions. When possible, vancomycin is given before anesthetic agents are started.
- Aminoglycoside antibiotics (e.g., gentamicin, tobramycin): These drugs are also toxic to the kidneys and ears; using them together with vancomycin raises the risk of both kidney damage and hearing loss.
- Other nephrotoxic or ototoxic drugs: Any medication that can stress the kidneys or harm hearing requires closer monitoring of kidney function when used at the same time as vancomycin.
This is not a complete list of interactions. Always talk with your doctor or pharmacist before starting, stopping, or changing any medication.
📋Before taking it▾
- Allergy to vancomycin: Do not take it — this is a contraindication. Tell your doctor about any past reactions.
- Allergy to corn or corn products: Some IV formulations contain dextrose (derived from corn) and may be contraindicated.
- Kidney problems: Vancomycin is cleared almost entirely by the kidneys; doses must be adjusted and function carefully monitored.
- Hearing loss: Pre-existing hearing problems increase the risk of ototoxicity; tell your doctor before starting treatment.
- Pregnancy (first or second trimester): The specific IV formulation containing PEG 400 and NADA must be avoided; use an alternative vancomycin formulation if treatment is needed. Discuss with your doctor.
- Breastfeeding: There is insufficient data on vancomycin levels in breast milk; discuss with your doctor before breastfeeding while on vancomycin.
- Older adults (65+): More likely to have reduced kidney function; kidney function should be monitored closely during and after treatment, even if baseline kidney function seems normal.
- Children and newborns: Vancomycin is used in pediatric patients with appropriate dose adjustments; infusion reactions may be more severe in children. Serum levels and kidney function should be monitored.
- Inflammatory bowel disease: Patients with active gut inflammation may absorb more oral vancomycin into the bloodstream than usual, increasing the risk of systemic side effects.
🚑If you take too much▾
If too much vancomycin is given, supportive care is the main treatment — there is no specific antidote. Vancomycin is not well removed by standard dialysis, though certain advanced filtering techniques (hemofiltration, hemoperfusion with polysulfone resin) may help increase clearance. Contact a Regional Poison Control Center immediately if overdose is suspected.
📡Pharmacodynamics — effects in the body▾
Vancomycin's ability to fight infection is linked to the total amount of drug the body is exposed to over time relative to how resistant the bacteria are — a measure called the AUC/MIC ratio. Essentially, the more drug exposure compared to how much it takes to inhibit the bacteria, the better the outcome. This relationship has been observed in animal models, particularly for MRSA, though the best clinical measure of effectiveness has not been fully established in human trials.
🔬Pharmacokinetics — how your body processes it▾
Vancomycin is given intravenously for most serious infections because it is poorly absorbed when taken by mouth — oral doses stay mostly in the gut, which is exactly what's needed for treating C. diff and gut infections. When given IV, it distributes widely into body fluids including pleural fluid, joint fluid, and urine, but does not easily cross into the spinal fluid unless the brain's protective membranes are inflamed. The drug is about 55% bound to proteins in the blood and is not significantly broken down (metabolized) by the body. It is eliminated almost entirely unchanged through the kidneys, with a normal half-life of 4 to 6 hours — but in people with kidney failure, that can stretch to 7.5 days, making dose adjustments critical. Older adults typically clear the drug more slowly as well.
📦How to store it▾
Store below 25°C (77ºF), in original package.
📄 Written from Vancomycin’s FDA-approved label information, summarized in plain language with AI, and reviewed by our pharmacy team before publication. Every point is grounded in that labeling — nothing is invented. How we use AI →
Supplements & herbs that interact with Vancomycin
50 supplements and herbal products have documented interactions with Vancomycin in the licensed clinical database we use. Most are manageable — but your pharmacist should know about everything you take, including vitamins and herbals.
- Major · 3
- Moderate · 36
- Minor · 11
Educational information from a licensed clinical database (Natural Medicines) — see our data sources & update cadence. Not medical advice: an interaction being documented does not mean it will happen to you; do not start or stop medications or supplements without professional guidance.
Nutrient depletion considerations
Vancomycin has been associated with lower levels of 7 nutrients in the clinical literature. This does not mean a deficiency will occur — it means these may be worth discussing with your pharmacist or healthcare provider, especially with long-term use.
- Higher significance · 6
- Moderate · 1
Educational information from a licensed clinical database (Natural Medicines) — not medical advice. Do not start or stop medications or supplements without professional guidance.
🩺 Pharmacist Counseling Corner
Quick, plain-English answers to the questions patients ask most about Vancomycin — the kind of thing our pharmacy team would talk through with you at the counter.
Why do I need an IV antibiotic — can't I just take a pill? ▾
What should I watch out for while taking vancomycin? ▾
Will vancomycin affect my kidneys? ▾
I'm pregnant — is vancomycin safe for me? ▾
Do I need to take the full course even if I feel better? ▾
Are there any other medicines I should avoid while on vancomycin? ▾
Is Vancomycin available over the counter? ▾
When was Vancomycin first available? ▾
Who makes Vancomycin? ▾
💬 Answers drafted from Vancomycin’s FDA-approved label information, summarized in plain language with AI, and reviewed by our pharmacy team before publication. Grounded in that labeling — nothing is made up. How we use AI →
🧰 Keep exploring
💊 How Vancomycin comes
Vancomycin is available in 3 forms. Different forms and brands can have different approved uses, doses, schedules, and directions. Follow the instructions for your exact product, and do not switch forms without guidance from your prescriber or pharmacist.
Injection
Show 31 more strengths Show fewer strengths
Capsule
Oral solution
📊 Vancomycin across the U.S. market
How Vancomycin appears in the FDA’s National Drug Code Directory — including its dosage forms, strengths, brand names, manufacturers, and FDA-listed product records. These are directory records, not sales or prescription volume.
FDA-listed product records by dose form (tablet variants merged) — FDA National Drug Code Directory. Record counts are not sales or prescription volume.
Also listed with the FDA, not a patient dose form: Kit (36) · Powder (21) — bulk drug substance sold to compounders/manufacturers and multi-item kits. These aren’t counted in the dose-form total above.
Share of FDA-listed product records by manufacturer — FDA National Drug Code Directory. Record counts are not sales or prescription volume.
📈 How widely Vancomycin is used
A general measure of how commonly Vancomycin is prescribed, based on Medicaid — one of the largest public drug programs. The figure below is prescriptions filled in Q1–Q4 2025, summed across every form and brand of the drug.
Think of this as a proxy for how widely Vancomycin is used, drawn from freely available public data. Medicaid is just one program — these numbers don’t include Medicare, other government coverage, or commercial and cash-pay prescriptions, so real-world use is higher than what’s shown here.
How commonly is Vancomycin prescribed? Of the 1,596 medications we measure, Vancomycin ranks #440 by Medicaid prescriptions — more than 72% of them.
Utilization by Vancomycin product
Pick a product to see its own Medicaid numbers. Each chip is one clinical product — a specific strength & dosage form as defined by RxNorm — with brand-name and generic versions combined.
vancomycin 1000 MG Injection Most dispensed
Summed across the 13 of 55 listed NDC products with Medicaid activity — every brand and generic of this exact strength & form. RxNorm 1807513
vancomycin 125 MG Oral Capsule
Summed across the 8 of 30 listed NDC products with Medicaid activity — every brand and generic of this exact strength & form. RxNorm 313570
vancomycin 100 MG/ML Injectable Solution
Summed across the 10 of 22 listed NDC products with Medicaid activity — every brand and generic of this exact strength & form. RxNorm 239209
200 ML vancomycin 5 MG/ML Injection
Summed across the 3 of 8 listed NDC products with Medicaid activity — every brand and generic of this exact strength & form. RxNorm 1807508
vancomycin 50 MG/ML Injectable Solution
Summed across the 8 of 18 listed NDC products with Medicaid activity — every brand and generic of this exact strength & form. RxNorm 313572
vancomycin 500 MG Injection
Summed across the 8 of 52 listed NDC products with Medicaid activity — every brand and generic of this exact strength & form. RxNorm 1807516
250 ML vancomycin 5 MG/ML Injection
Summed across the 2 of 5 listed NDC products with Medicaid activity — every brand and generic of this exact strength & form. RxNorm 2387078
300 ML vancomycin 5 MG/ML Injection
Summed across the 2 of 5 listed NDC products with Medicaid activity — every brand and generic of this exact strength & form. RxNorm 2118448
vancomycin 250 MG Oral Capsule
Summed across the 4 of 31 listed NDC products with Medicaid activity — every brand and generic of this exact strength & form. RxNorm 313571
vancomycin 50 MG/ML Oral Solution
Summed across the 8 of 23 listed NDC products with Medicaid activity — every brand and generic of this exact strength & form. RxNorm 2000134
150 ML vancomycin 5 MG/ML Injection
Summed across the 3 of 8 listed NDC products with Medicaid activity — every brand and generic of this exact strength & form. RxNorm 1807510
vancomycin 750 MG Injection
Summed across the 6 of 22 listed NDC products with Medicaid activity — every brand and generic of this exact strength & form. RxNorm 1807518
vancomycin 1250 MG Injection
Summed across the 5 of 16 listed NDC products with Medicaid activity — every brand and generic of this exact strength & form. RxNorm 2049888
vancomycin 1500 MG Injection
Summed across the 4 of 18 listed NDC products with Medicaid activity — every brand and generic of this exact strength & form. RxNorm 2049890
100 ML vancomycin 5 MG/ML Injection
Summed across the 3 of 8 listed NDC products with Medicaid activity — every brand and generic of this exact strength & form. RxNorm 1807511
vancomycin 25 MG/ML Oral Solution
Summed across the 6 of 7 listed NDC products with Medicaid activity — every brand and generic of this exact strength & form. RxNorm 2000127
350 ML vancomycin 5 MG/ML Injection
Summed across the 1 of 4 listed NDC products with Medicaid activity — every brand and generic of this exact strength & form. RxNorm 2387079
400 ML vancomycin 5 MG/ML Injection
Summed across the 1 of 4 listed NDC products with Medicaid activity — every brand and generic of this exact strength & form. RxNorm 2118449
vancomycin 1750 MG Injection
Summed across the 1 of 2 listed NDC products with Medicaid activity — every brand and generic of this exact strength & form. RxNorm 2688632
vancomycin 2000 MG Injection
Summed across the 1 of 2 listed NDC products with Medicaid activity — every brand and generic of this exact strength & form. RxNorm 2688634
Shares are of the Medicaid prescriptions shown here. Product grouping follows RxNorm (the National Library of Medicine’s drug terminology), so “one product” means one strength & dosage form regardless of manufacturer. Dollar figures are gross Medicaid reimbursement before mandatory rebates — rebates (often large, especially for brand-name drugs) are confidential, so actual net cost to Medicaid is lower than shown.
Source: Medicaid State Drug Utilization Data (CMS), aggregated by generic ingredient — summed across every NDC (all brands, strengths, salt forms and dosage forms) of Vancomycin, and across all states and both fee-for-service and managed-care claims. A general popularity signal; it excludes Medicare, commercial insurance and cash prescriptions, so it is not total U.S. use. Based on the 97 of 340 listed Vancomycin NDCs with Medicaid activity.
🔍 Compare Vancomycin products
A representative set of FDA-listed product records for Vancomycin — across manufacturers, strengths, and dosage forms, grouped by form with each product’s manufacturer and how the FDA approved it. The same medicine may be made and packaged by different companies, so a single drug can have many directory entries. (It’s also why a refill can look different — a new shape, color, or box — even though it contains the same medication.)
| Strength | Route | Manufacturer / Labeler | Category ⓘ | Details |
|---|---|---|---|---|
| 💊Capsule | ||||
| 250 mg | Oral | Advanced Rx of Tennessee, LLC | NDA AUTHORIZED GENERIC | View NDC → |
| 125 mg | Oral | Akorn | ANDA | View NDC → |
| 250 mg | Oral | Akorn | ANDA | View NDC → |
| 125 mg | Oral | Alvogen Inc. × 2 listings | ANDA | View NDC → |
| 250 mg | Oral | Alvogen Inc. × 2 listings | ANDA | View NDC → |
| 125 mg | Oral | ANI Pharmaceuticals, Inc. × 2 listings | NDA | View NDC → |
| 125 mg | Oral | ANI Pharmaceuticals, Inc. × 2 listings | NDA AUTHORIZED GENERIC | View NDC → |
| 250 mg | Oral | ANI Pharmaceuticals, Inc. × 2 listings | NDA | View NDC → |
| 250 mg | Oral | ANI Pharmaceuticals, Inc. × 2 listings | NDA AUTHORIZED GENERIC | View NDC → |
| 125 mg | Oral | Bryant Ranch Prepack × 2 listings | ANDA | View NDC → |
| 250 mg | Oral | Bryant Ranch Prepack × 2 listings | ANDA | View NDC → |
| 125 mg | Oral | Cameron Pharmaceuticals × 2 listings | ANDA | View NDC → |
| 250 mg | Oral | Cameron Pharmaceuticals × 2 listings | ANDA | View NDC → |
| 125 mg | Oral | Heritage Pharmaceuticals Inc. d/b/a Avet Pharmaceuticals Inc. × 3 listings | ANDA | View NDC → |
| 250 mg | Oral | Heritage Pharmaceuticals Inc. d/b/a Avet Pharmaceuticals Inc. × 3 listings | ANDA | View NDC → |
| 125 mg | Oral | Lupin Pharmaceuticals, Inc. × 2 listings | ANDA | View NDC → |
| 250 mg | Oral | Lupin Pharmaceuticals, Inc. × 2 listings | ANDA | View NDC → |
| 125 mg | Oral | Orient Pharma Co.,Ltd Yunlin Plant | ANDA | View NDC → |
| 250 mg | Oral | Orient Pharma Co.,Ltd Yunlin Plant | ANDA | View NDC → |
| 125 mg | Oral | PAI Holdings, LLC × 2 listings | ANDA | View NDC → |
| 250 mg | Oral | PAI Holdings, LLC × 2 listings | ANDA | View NDC → |
| 125 mg | Oral | PAI Holdings, LLC dba PAI Pharma | ANDA | View NDC → |
| 250 mg | Oral | PAI Holdings, LLC dba PAI Pharma | ANDA | View NDC → |
| 125 mg | Oral | Pharmaceutical Associates, Inc. × 2 listings | ANDA | View NDC → |
| 250 mg | Oral | Pharmaceutical Associates, Inc. × 2 listings | ANDA | View NDC → |
| 125 mg | Oral | Redpharm Drug | NDA AUTHORIZED GENERIC | View NDC → |
| 125 mg | Oral | Redpharm Drug | ANDA | View NDC → |
| 125 mg | Oral | Remedyrepack Inc. | ANDA | View NDC → |
| 125 mg | Oral | Strides Pharma Science Limited | ANDA | View NDC → |
| 250 mg | Oral | Strides Pharma Science Limited | ANDA | View NDC → |
| 💊Injection | ||||
| 500 mg/10 mL | Intravenous | Almaject, Inc. × 2 listings | ANDA | View NDC → |
| 1 g/20 mL | Intravenous | Almaject, Inc. × 2 listings | ANDA | View NDC → |
| 500 mg/10 mL | Intravenous | Athenex Pharmaceutical Division, LLC. | ANDA | View NDC → |
| 1 g/20 mL | Intravenous | Athenex Pharmaceutical Division, LLC. | ANDA | View NDC → |
| 500 mg/10 mL | Intravenous | AuroMedics Pharma LLC | ANDA | View NDC → |
| 1 g/20 mL | Intravenous | AuroMedics Pharma LLC | ANDA | View NDC → |
| 5 g | Intravenous | AuroMedics Pharma LLC | ANDA | View NDC → |
| 10 g | Intravenous | AuroMedics Pharma LLC | ANDA | View NDC → |
| 750 mg | Intravenous, Oral | Avenacy, LLC | NDA | View NDC → |
| 1.25 g | Intravenous, Oral | Avenacy, LLC | NDA | View NDC → |
| 1.5 g | Intravenous, Oral | Avenacy, LLC | NDA | View NDC → |
| 500 mg | Intravenous | BluePoint Laboratories | ANDA | View NDC → |
| 1 g | Intravenous | BluePoint Laboratories | ANDA | View NDC → |
| 5 g | Intravenous | BluePoint Laboratories | ANDA | View NDC → |
| 10 g | Intravenous | BluePoint Laboratories | ANDA | View NDC → |
| 500 mg/10 mL | Intravenous | Camber Pharmaceuticals, Inc. | ANDA | View NDC → |
| 1 g/20 mL | Intravenous | Camber Pharmaceuticals, Inc. | ANDA | View NDC → |
| 500 mg/5 mL | Intravenous | Civica, Inc | ANDA | View NDC → |
| 500 mg/10 mL | Intravenous | Civica, Inc | ANDA | View NDC → |
| 1 g | Intravenous | Civica, Inc | ANDA | View NDC → |
| 1 g/10 mL | Intravenous | Civica, Inc. × 2 listings | ANDA | View NDC → |
| 5 g/100 mL | Intravenous | Civica, Inc. | ANDA | View NDC → |
| 10 g/100 mL | Intravenous | Civica, Inc. | ANDA | View NDC → |
| 500 mg/10 mL | Intravenous | Eugia US LLC × 2 listings | ANDA | View NDC → |
| 1 g/20 mL | Intravenous | Eugia US LLC × 2 listings | ANDA | View NDC → |
| 1.25 g/25 mL | Intravenous | Eugia US LLC | ANDA | View NDC → |
| 1.5 g/30 mL | Intravenous | Eugia US LLC | ANDA | View NDC → |
| 5 g | Intravenous | Eugia US LLC × 2 listings | ANDA | View NDC → |
| 10 g | Intravenous | Eugia US LLC × 2 listings | ANDA | View NDC → |
| 500 mg/10 mL | Intravenous | Eurofarma, Inc. | ANDA | View NDC → |
| 1 g/20 mL | Intravenous | Eurofarma, Inc. | ANDA | View NDC → |
| 500 mg/10 mL | Intravenous | Fresenius Kabi, LLC × 4 listings | ANDA | View NDC → |
| 1 g/20 mL | Intravenous | Fresenius Kabi, LLC × 2 listings | ANDA | View NDC → |
| 10 g/100 mL | Intravenous | Fresenius Kabi, LLC | ANDA | View NDC → |
| 500 mg/10 mL | Intravenous | Fresenius Kabi USA, LLC × 4 listings | ANDA | View NDC → |
| 750 mg/15 mL | Intravenous | Fresenius Kabi USA, LLC × 5 listings | ANDA | View NDC → |
| 1 g/20 mL | Intravenous | Fresenius Kabi USA, LLC × 6 listings | ANDA | View NDC → |
| 5 g/100 mL | Intravenous | Fresenius Kabi USA, LLC × 3 listings | ANDA | View NDC → |
| 10 g/100 mL | Intravenous | Fresenius Kabi USA, LLC × 3 listings | ANDA | View NDC → |
| 500 mg | Intravenous | General Injectables & Vaccines, Inc | ANDA | View NDC → |
| 500 mg/10 mL | Intravenous | Gland Pharma Limited × 2 listings | ANDA | View NDC → |
| 750 mg | Intravenous | Gland Pharma Limited | ANDA | View NDC → |
| 1 g/20 mL | Intravenous | Gland Pharma Limited × 2 listings | ANDA | View NDC → |
| 1.25 g | Intravenous | Gland Pharma Limited | ANDA | View NDC → |
| 1.5 g | Intravenous | Gland Pharma Limited | ANDA | View NDC → |
| 5 g/100 mL | Intravenous | Gland Pharma Limited | ANDA | View NDC → |
| 10 g/100 mL | Intravenous | Gland Pharma Limited | ANDA | View NDC → |
| 500 mg/10 mL | Intravenous | Glenmark Pharmaceuticals Inc., Usa | ANDA | View NDC → |
| 750 mg | Intravenous | Glenmark Pharmaceuticals Inc., Usa | ANDA | View NDC → |
| 1 g/20 mL | Intravenous | Glenmark Pharmaceuticals Inc., Usa | ANDA | View NDC → |
| 1.25 g | Intravenous | Glenmark Pharmaceuticals Inc., Usa | ANDA | View NDC → |
| 1.5 g | Intravenous | Glenmark Pharmaceuticals Inc., Usa | ANDA | View NDC → |
| 500 mg | Intravenous | Henry Schein, Inc. × 3 listings | ANDA | View NDC → |
| 500 mg | Intravenous | Hikma Pharmaceuticals USA Inc. | ANDA | View NDC → |
| 513 mg/mg | Intravenous, Oral | Hikma Pharmaceuticals Usa Inc. | NDA | View NDC → |
| 513 mg/mg | Intravenous; Oral | Hikma Pharmaceuticals Usa Inc. | NDA | View NDC → |
| 750 mg | Intravenous | Hikma Pharmaceuticals USA Inc. | ANDA | View NDC → |
| 769 mg/mg | Intravenous, Oral | Hikma Pharmaceuticals Usa Inc. | NDA | View NDC → |
| 1 g | Intravenous | Hikma Pharmaceuticals USA Inc. | ANDA | View NDC → |
| 1025 mg/mg | Intravenous, Oral | Hikma Pharmaceuticals Usa Inc. | NDA | View NDC → |
| 1025 mg/mg | Intravenous; Oral | Hikma Pharmaceuticals Usa Inc. | NDA | View NDC → |
| 1.25 g | Intravenous | Hikma Pharmaceuticals USA Inc. × 2 listings | ANDA | View NDC → |
| 1280 mg/mg | Intravenous, Oral | Hikma Pharmaceuticals Usa Inc. | NDA | View NDC → |
| 1.5 g | Intravenous | Hikma Pharmaceuticals USA Inc. × 2 listings | ANDA | View NDC → |
| 1540 mg/mg | Intravenous, Oral | Hikma Pharmaceuticals Usa Inc. | NDA | View NDC → |
| 5 g | Intravenous | Hikma Pharmaceuticals USA Inc. | ANDA | View NDC → |
| 5.13 g/g | Intravenous, Oral | Hikma Pharmaceuticals Usa Inc. | NDA | View NDC → |
| 5.13 g/g | Intravenous; Oral | Hikma Pharmaceuticals Usa Inc. | NDA | View NDC → |
| 10 g | Intravenous | Hikma Pharmaceuticals USA Inc. | ANDA | View NDC → |
| 10.25 g/g | Intravenous, Oral | Hikma Pharmaceuticals Usa Inc. | NDA | View NDC → |
| 10.25 g/g | Intravenous; Oral | Hikma Pharmaceuticals Usa Inc. | NDA | View NDC → |
| 100 mg/mL | Intravenous | Hospira, Inc. | ANDA | View NDC → |
| 500 mg | Intravenous | Hospira, Inc. × 4 listings | ANDA | View NDC → |
| 500 mg/5 mL | Intravenous | Hospira, Inc. × 6 listings | ANDA | View NDC → |
| 500 mg/10 mL | Intravenous | Hospira, Inc. × 7 listings | ANDA | View NDC → |
| 750 mg | Intravenous | Hospira, Inc. × 4 listings | ANDA | View NDC → |
| 1 g | Intravenous | Hospira, Inc. × 6 listings | ANDA | View NDC → |
| 1.5 g | Intravenous | Hospira, Inc. × 3 listings | ANDA | View NDC → |
| 500 mg/10 mL | Intravenous | Meitheal Pharmaceuticals Inc. × 3 listings | ANDA | View NDC → |
| 750 mg/15 mL | Intravenous | Meitheal Pharmaceuticals Inc. × 2 listings | ANDA | View NDC → |
| 1 g/20 mL | Intravenous | Meitheal Pharmaceuticals Inc. × 3 listings | ANDA | View NDC → |
| 5 g/100 mL | Intravenous | Meitheal Pharmaceuticals Inc. × 2 listings | ANDA | View NDC → |
| 10 g/95 mL | Intravenous | Meitheal Pharmaceuticals Inc. × 2 listings | ANDA | View NDC → |
| 500 mg | Intravenous | Xellia Pharmaceuticals USA LLC | ANDA | View NDC → |
| 1 g | Intravenous | Xellia Pharmaceuticals USA LLC | ANDA | View NDC → |
| 10.25 g/g | Intravenous, Oral | Zhejiang Novus Pharma Co., Ltd. | NDA | View NDC → |
Showing 200 of 392 products — FDA National Drug Code Directory. See every product, package size and price: browse all 392 Vancomycin NDCs →
📈 What people report — real-world data (FDA FAERS)
After a medicine reaches the market, patients, doctors and drugmakers can send the FDA reports of problems they think may be linked to it. Here’s what’s been reported for Vancomycin — a signal of what to watch for, not proof the drug caused it.
Source: openFDA, from the FDA Adverse Event Reporting System (FAERS). These are voluntary reports — they don’t prove the drug caused the effect, and counts reflect how often something was reported, not how often it actually happens. Reports also often name the very problem the medicine is taken for — a common reason to file one is that the drug didn’t help — so for a pain reliever you may see “pain” high on the list; that points to why the report was filed, not to the drug causing the symptom. This counts every report that lists Vancomycin in any role, so the total runs higher than the FDA’s official dashboard, which counts only cases where the drug is the suspect. For the authoritative figures, see the FDA FAERS Public Dashboard. Always talk to your pharmacist or doctor.
🏛️ The road to your pharmacy
How Vancomycin went from FDA review to the pharmacy shelf — the key milestones in its regulatory journey.
Source: Drugs@FDA.
🚨 Recall history
A recall is when a specific batch of a medicine is pulled from the market — usually a manufacturing issue, not a problem with the drug itself. Class I is most serious, Class III least.
Source: openFDA drug enforcement (recall) reports.
RxNorm Concept Web — From Ingredient to Every Form and Strength
This page starts with one ingredient concept (IN). The branches below show its dose-form concepts (SCDF), then the available clinical drug and strength concepts (SCD). Combination products remain separate concepts with their own pages.
RxCUI 11124 4 dose forms · 21 strengths
-
Dose form (SCDF) Injectable Solution RxCUI 375983In current FDA listings -
Dose form (SCDF) Injection RxCUI 1807507In current FDA listingsClinical drug / strength (SCD) 100 ML vancomycin 5 MG/MLRxCUI 1807511150 ML vancomycin 5 MG/MLRxCUI 1807510200 ML vancomycin 5 MG/MLRxCUI 1807508250 MGRxCUI 2049891250 ML vancomycin 5 MG/MLRxCUI 2387078300 ML vancomycin 5 MG/MLRxCUI 2118448350 ML vancomycin 5 MG/MLRxCUI 2387079400 ML vancomycin 5 MG/MLRxCUI 2118449500 MGRxCUI 1807516750 MGRxCUI 18075181000 MGRxCUI 18075131250 MGRxCUI 20498881500 MGRxCUI 20498901750 MGRxCUI 26886322000 MGRxCUI 2688634 -
Dose form (SCDF) Oral Capsule RxCUI 374281In current FDA listings -
Dose form (SCDF) Oral Solution RxCUI 374282In current FDA listings
Look up RxCUI 11124 in the RxCUI Atlas →
RxNorm is the U.S. National Library of Medicine’s normalized drug vocabulary. Its concept hierarchy can include forms that are not currently marketed; the status on each branch compares that concept with current FDA listings. RxCUIs identify vocabulary concepts, not individual packages or manufacturers.
📦 Supply & shortage status
Whether Vancomycin is in short supply in the U.S. right now, plus any shortage history the FDA has on record. A shortage usually reflects a manufacturing or demand issue — not a safety problem with the drug.
Source: openFDA, from the FDA Drug Shortages database.
🏷️ Sold under these brand names
🏭 Manufacturers & labelers
…and 16 more on the FDA NDC directory.
RxNorm drug class
Vancomycin belongs to the Glycopeptide Antibacterial class.
Classified by RxNorm RxClass — the U.S. National Library of Medicine's standardized drug-classification service (Established Pharmacologic Class from the FDA, the ATC drug family from the WHO, and mechanism of action). Reference only, not medical advice.
🔬 Where this comes from
Core label, product, RxNorm, safety, and utilization data on this page come from the sources identified below. AI-written, editorial, and licensed sections are labeled separately.
How we combine label and product data
HelloPharmacist combines public FDA and NLM records; we don’t author the underlying clinical facts. We identified 57 FDA-filed SPL label sets within the page’s selected clinical scope after exact ingredient or ingredient-combination matching and applicable route/form matching. The representative label is the starting point for the displayed reference monograph; the 12 largest stored in-scope SPL records, which may include that representative, are compared section by section, and the longest available version of each section is retained. Forms, routes, brands, labelers, product-listed strengths, and product-record counts are aggregated separately from ingredient-matched FDA NDC Directory records; package records listed above are associated with the linked SPL; and the normalized concept hierarchy comes from NLM RxNorm.
For canonical ingredient pages, bounded product-attributed indication and administration excerpts may be added to the AI evidence, and the generator is instructed to preserve available product, brand, route, and form qualifiers instead of treating one label as universal. Where a section is identified as AI-written, its plain-language text is generated from bounded label evidence. New draft drug pages remain in the admin review queue before first publication. Hikma Pharmaceuticals USA Inc. is the representative DailyMed label linked for verification and dates; it is not the sole source used for the page.
This is general education, not medical advice — always consult your doctor or pharmacist about your medications and any medical condition. For the exact wording of the linked representative label, view that label on DailyMed; some displayed composite sections may come from other in-scope SPL labels. Learn how we use AI and our data sources & update cadence.